Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil plus lidocaine versus morphine plus lidocaine for prevention of peri-intubation hypertension and tachycardia during laparoscopic cholecystectomy
IRCT20210807052100N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Jan 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sufentanil, morphine and lidocaine in cholecystitis (2 arms), sponsored by Islamic Azad University. Primary endpoints: Systolic blood pressure, Mean arterial pressure and 1 more. Started Jan 2021; status: completed.
02
Drugs
sufentanilmorphinelidocaine
03
Conditions
cholecystitis
Beyond the preview
Go deeper on IRCT20210807052100N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210807052100N1.